Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04589676 · ClinicalTrials.gov registry record · NA
Developing and Testing the Opioid Rapid Response System
A NA study, sponsored by Real Prevention.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT04589676: Completed NA study, sponsored by Real Prevention.
NCT04589676 is a NA study that has completed, run by Real Prevention. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04589676, a NA study, has completed, sponsored by Real Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
This Phase I SBIR will develop and demonstrate the usability/feasibility of the Opioid Rapid Response System (OSSR) in order to reduce deaths and strain on emergency response systems from opioid overdoses.
Primary Outcome
Self report survey scale to measure perceptions of training using agree-disagree scale that yields a composite score of rating that the training is worth the investment of their time and they would recommend it to others in their community.
Interventions
- BEHAVIORAL Naloxone training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT04589676 record still lists
NCT04589676 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which Naloxone training is the first listed.
NCT04589676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04589676 about?
NCT04589676 is a clinical study titled "Developing and Testing the Opioid Rapid Response System". This Phase I SBIR will develop and demonstrate the usability/feasibility of the Opioid Rapid Response System (OSSR) in order to reduce deaths and strain on emergency response systems from opioid overdoses.
What is the current status of trial NCT04589676?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2020-12-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04589676?
The interventions under investigation include: Naloxone training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04589676?
This trial is sponsored by Real Prevention, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04589676's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI